Global and United States RNA Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18918192 | Publishing Date : 16-Aug-2021 | No. of pages : 153
Detailed TOC of Global and United States RNA Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 RNA Drugs Product Introduction
1.2 Market by Type
1.2.1 Global RNA Drugs Market Size Growth Rate by Type
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Drugs Market Size Growth Rate by Application
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Drugs Market Size, Estimates and Forecasts
2.1.1 Global RNA Drugs Revenue 2016-2027
2.1.2 Global RNA Drugs Sales 2016-2027
2.2 Global RNA Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 RNA Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 RNA Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global RNA Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global RNA Drugs Revenue Forecast by Region (2022-2027)
3 Global RNA Drugs Competitor Landscape by Players
3.1 Global Top RNA Drugs Manufacturers by Sales
3.1.1 Global RNA Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global RNA Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top RNA Drugs Manufacturers by Revenue
3.2.1 Key RNA Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global RNA Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global RNA Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global RNA Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2020
3.2.6 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global RNA Drugs Price by Manufacturers
3.4 Global RNA Drugs Manufacturing Base Distribution, Product Types
3.4.1 RNA Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA Drugs Product Type
3.4.3 Date of International Manufacturers Enter into RNA Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global RNA Drugs Market Size by Type (2016-2021)
4.1.1 Global RNA Drugs Sales by Type (2016-2021)
4.1.2 Global RNA Drugs Revenue by Type (2016-2021)
4.1.3 RNA Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global RNA Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global RNA Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global RNA Drugs Revenue Forecast by Type (2022-2027)
4.2.3 RNA Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global RNA Drugs Market Size by Application (2016-2021)
5.1.1 Global RNA Drugs Sales by Application (2016-2021)
5.1.2 Global RNA Drugs Revenue by Application (2016-2021)
5.1.3 RNA Drugs Price by Application (2016-2021)
5.2 RNA Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global RNA Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global RNA Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global RNA Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States RNA Drugs Market Size YoY Growth 2016-2027
6.1.1 United States RNA Drugs Sales YoY Growth 2016-2027
6.1.2 United States RNA Drugs Revenue YoY Growth 2016-2027
6.1.3 United States RNA Drugs Market Share in Global Market 2016-2027
6.2 United States RNA Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top RNA Drugs Players by Sales (2016-2021)
6.2.2 United States Top RNA Drugs Players by Revenue (2016-2021)
6.3 United States RNA Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States RNA Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States RNA Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States RNA Drugs Price by Type (2016-2021)
6.4 United States RNA Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States RNA Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States RNA Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States RNA Drugs Price Forecast by Type (2022-2027)
6.5 United States RNA Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States RNA Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States RNA Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States RNA Drugs Price by Application (2016-2021)
6.6 United States RNA Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States RNA Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States RNA Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States RNA Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America RNA Drugs Market Size YoY Growth 2016-2027
7.2 North America RNA Drugs Market Facts & Figures by Country
7.2.1 North America RNA Drugs Sales by Country (2016-2021)
7.2.2 North America RNA Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific RNA Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific RNA Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific RNA Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific RNA Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe RNA Drugs Market Size YoY Growth 2016-2027
9.2 Europe RNA Drugs Market Facts & Figures by Country
9.2.1 Europe RNA Drugs Sales by Country (2016-2021)
9.2.2 Europe RNA Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America RNA Drugs Market Size YoY Growth 2016-2027
10.2 Latin America RNA Drugs Market Facts & Figures by Country
10.2.1 Latin America RNA Drugs Sales by Country (2016-2021)
10.2.2 Latin America RNA Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa RNA Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa RNA Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa RNA Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa RNA Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer RNA Drugs Products Offered
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Description and Business Overview
12.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche RNA Drugs Products Offered
12.2.5 Roche Recent Development
12.3 Sanofi-Aventis
12.3.1 Sanofi-Aventis Corporation Information
12.3.2 Sanofi-Aventis Description and Business Overview
12.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi-Aventis RNA Drugs Products Offered
12.3.5 Sanofi-Aventis Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Corporation Information
12.4.2 Abbott Laboratories Description and Business Overview
12.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Laboratories RNA Drugs Products Offered
12.4.5 Abbott Laboratories Recent Development
12.5 Arrowhead Pharmaceuticals
12.5.1 Arrowhead Pharmaceuticals Corporation Information
12.5.2 Arrowhead Pharmaceuticals Description and Business Overview
12.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Arrowhead Pharmaceuticals RNA Drugs Products Offered
12.5.5 Arrowhead Pharmaceuticals Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Corporation Information
12.6.2 Benitec Biopharma Description and Business Overview
12.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Benitec Biopharma RNA Drugs Products Offered
12.6.5 Benitec Biopharma Recent Development
12.7 Calimmune Inc
12.7.1 Calimmune Inc Corporation Information
12.7.2 Calimmune Inc Description and Business Overview
12.7.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Calimmune Inc RNA Drugs Products Offered
12.7.5 Calimmune Inc Recent Development
12.8 Dicerna
12.8.1 Dicerna Corporation Information
12.8.2 Dicerna Description and Business Overview
12.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dicerna RNA Drugs Products Offered
12.8.5 Dicerna Recent Development
12.9 Gradalis
12.9.1 Gradalis Corporation Information
12.9.2 Gradalis Description and Business Overview
12.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Gradalis RNA Drugs Products Offered
12.9.5 Gradalis Recent Development
12.10 Quark
12.10.1 Quark Corporation Information
12.10.2 Quark Description and Business Overview
12.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Quark RNA Drugs Products Offered
12.10.5 Quark Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer RNA Drugs Products Offered
12.11.5 Pfizer Recent Development
12.12 Senesco
12.12.1 Senesco Corporation Information
12.12.2 Senesco Description and Business Overview
12.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Senesco Products Offered
12.12.5 Senesco Recent Development
12.13 Silence Therapeutics
12.13.1 Silence Therapeutics Corporation Information
12.13.2 Silence Therapeutics Description and Business Overview
12.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Silence Therapeutics Products Offered
12.13.5 Silence Therapeutics Recent Development
12.14 Silenseed
12.14.1 Silenseed Corporation Information
12.14.2 Silenseed Description and Business Overview
12.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Silenseed Products Offered
12.14.5 Silenseed Recent Development
12.15 Tekmira
12.15.1 Tekmira Corporation Information
12.15.2 Tekmira Description and Business Overview
12.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Tekmira Products Offered
12.15.5 Tekmira Recent Development
12.16 Alnylam Pharmaceuticals
12.16.1 Alnylam Pharmaceuticals Corporation Information
12.16.2 Alnylam Pharmaceuticals Description and Business Overview
12.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Alnylam Pharmaceuticals Products Offered
12.16.5 Alnylam Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 RNA Drugs Industry Trends
13.2 RNA Drugs Market Drivers
13.3 RNA Drugs Market Challenges
13.4 RNA Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States RNA Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global RNA Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of siRNA
Table 3. Major Manufacturers of ASO
Table 4. Major Manufacturers of miRNA
Table 5. Major Manufacturers of Nucleic Acid Aptamers
Table 6. Global RNA Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global RNA Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global RNA Drugs Sales by Regions (2016-2021) & (K Units)
Table 9. Global RNA Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global RNA Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global RNA Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global RNA Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global RNA Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global RNA Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global RNA Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global RNA Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top RNA Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. RNA Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. RNA Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2020)
Table 22. Key Manufacturers RNA Drugs Price (2016-2021) (USD/Unit)
Table 23. RNA Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers RNA Drugs Product Type
Table 25. Date of International Manufacturers Enter into RNA Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global RNA Drugs Sales by Type (2016-2021) (K Units)
Table 28. Global RNA Drugs Sales Share by Type (2016-2021)
Table 29. Global RNA Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global RNA Drugs Revenue Share by Type (2016-2021)
Table 31. RNA Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global RNA Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global RNA Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global RNA Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global RNA Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global RNA Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global RNA Drugs Sales by Application (2016-2021) (K Units)
Table 38. Global RNA Drugs Sales Share by Application (2016-2021)
Table 39. Global RNA Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global RNA Drugs Revenue Share by Application (2016-2021)
Table 41. RNA Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global RNA Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global RNA Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global RNA Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global RNA Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global RNA Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. United States RNA Drugs Sales (K Units) of Key Companies (2016-2021)
Table 48. United States RNA Drugs Sales Share by Company (2016-2021)
Table 49. United States RNA Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. United States RNA Drugs Revenue Share by Company (2016-2021)
Table 51. United States RNA Drugs Sales (K Units) by Type (2016-2021)
Table 52. United States RNA Drugs Sales Share by Type (2016-2021)
Table 53. United States RNA Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States RNA Drugs Price (USD/Unit) by Type (2016-2021)
Table 55. United States RNA Drugs Sales (K Units) by Type (2022-2027)
Table 56. United States RNA Drugs Sales Share by Type (2022-2027)
Table 57. United States RNA Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States RNA Drugs Revenue Share by Type (2022-2027)
Table 59. United States RNA Drugs Price (USD/Unit) by Type (2022-2027)
Table 60. United States RNA Drugs Sales (K Units) by Application (2016-2021)
Table 61. United States RNA Drugs Sales Share by Application (2016-2021)
Table 62. United States RNA Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States RNA Drugs Price (USD/Unit) by Application (2016-2021)
Table 64. United States RNA Drugs Sales (K Units) by Application (2022-2027)
Table 65. United States RNA Drugs Sales Share by Application (2022-2027)
Table 66. United States RNA Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States RNA Drugs Revenue Share by Application (2022-2027)
Table 68. United States RNA Drugs Price (USD/Unit) by Application (2022-2027)
Table 69. North America RNA Drugs Sales by Country (2016-2021) & (K Units)
Table 70. North America RNA Drugs Sales Market Share by Country (2016-2021)
Table 71. North America RNA Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America RNA Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific RNA Drugs Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific RNA Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific RNA Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific RNA Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe RNA Drugs Sales by Country (2016-2021) & (K Units)
Table 78. Europe RNA Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe RNA Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe RNA Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America RNA Drugs Sales by Country (2016-2021) & (K Units)
Table 82. Latin America RNA Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa RNA Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America RNA Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa RNA Drugs Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa RNA Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa RNA Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa RNA Drugs Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Pfizer RNA Drugs Product
Table 93. Pfizer Recent Development
Table 94. Roche Corporation Information
Table 95. Roche Description and Business Overview
Table 96. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Roche Product
Table 98. Roche Recent Development
Table 99. Sanofi-Aventis Corporation Information
Table 100. Sanofi-Aventis Description and Business Overview
Table 101. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. Sanofi-Aventis Product
Table 103. Sanofi-Aventis Recent Development
Table 104. Abbott Laboratories Corporation Information
Table 105. Abbott Laboratories Description and Business Overview
Table 106. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Abbott Laboratories Product
Table 108. Abbott Laboratories Recent Development
Table 109. Arrowhead Pharmaceuticals Corporation Information
Table 110. Arrowhead Pharmaceuticals Description and Business Overview
Table 111. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Arrowhead Pharmaceuticals Product
Table 113. Arrowhead Pharmaceuticals Recent Development
Table 114. Benitec Biopharma Corporation Information
Table 115. Benitec Biopharma Description and Business Overview
Table 116. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. Benitec Biopharma Product
Table 118. Benitec Biopharma Recent Development
Table 119. Calimmune Inc Corporation Information
Table 120. Calimmune Inc Description and Business Overview
Table 121. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Calimmune Inc Product
Table 123. Calimmune Inc Recent Development
Table 124. Dicerna Corporation Information
Table 125. Dicerna Description and Business Overview
Table 126. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Dicerna Product
Table 128. Dicerna Recent Development
Table 129. Gradalis Corporation Information
Table 130. Gradalis Description and Business Overview
Table 131. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. Gradalis Product
Table 133. Gradalis Recent Development
Table 134. Quark Corporation Information
Table 135. Quark Description and Business Overview
Table 136. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Quark Product
Table 138. Quark Recent Development
Table 139. RXi Corporation Information
Table 140. RXi Description and Business Overview
Table 141. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. RXi Product
Table 143. RXi Recent Development
Table 144. Senesco Corporation Information
Table 145. Senesco Description and Business Overview
Table 146. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Senesco Product
Table 148. Senesco Recent Development
Table 149. Silence Therapeutics Corporation Information
Table 150. Silence Therapeutics Description and Business Overview
Table 151. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Silence Therapeutics Product
Table 153. Silence Therapeutics Recent Development
Table 154. Silenseed Corporation Information
Table 155. Silenseed Description and Business Overview
Table 156. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 157. Silenseed Product
Table 158. Silenseed Recent Development
Table 159. Tekmira Corporation Information
Table 160. Tekmira Description and Business Overview
Table 161. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 162. Tekmira Product
Table 163. Tekmira Recent Development
Table 164. Alnylam Pharmaceuticals Corporation Information
Table 165. Alnylam Pharmaceuticals Description and Business Overview
Table 166. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 167. Alnylam Pharmaceuticals Product
Table 168. Alnylam Pharmaceuticals Recent Development
Table 169. RNA Drugs Market Trends
Table 170. RNA Drugs Market Drivers
Table 171. RNA Drugs Market Challenges
Table 172. RNA Drugs Market Restraints
Table 173. RNA Drugs Customers List
Table 174. RNA Drugs Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 2. Global RNA Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. RNA Drugs Report Years Considered
Figure 14. Global RNA Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global RNA Drugs Market Size 2016-2027 (US$ Million)
Figure 16. Global RNA Drugs Sales 2016-2027 (K Units)
Figure 17. Global RNA Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global RNA Drugs Sales Market Share by Region (2016-2021)
Figure 19. Global RNA Drugs Sales Market Share by Region in 2020
Figure 20. Global RNA Drugs Revenue Market Share by Region (2016-2021)
Figure 21. Global RNA Drugs Revenue Market Share by Region in 2020
Figure 22. Global RNA Drugs Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by RNA Drugs Revenue in 2020
Figure 24. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global RNA Drugs Sales Market Share by Type (2016-2021)
Figure 26. Global RNA Drugs Sales Market Share by Type in 2020
Figure 27. Global RNA Drugs Revenue Market Share by Type (2016-2021)
Figure 28. Global RNA Drugs Revenue Market Share by Type in 2020
Figure 29. Global RNA Drugs Sales Market Share by Application (2016-2021)
Figure 30. Global RNA Drugs Sales Market Share by Application in 2020
Figure 31. Global RNA Drugs Revenue Market Share by Application (2016-2021)
Figure 32. Global RNA Drugs Revenue Market Share by Application in 2020
Figure 33. United States RNA Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 34. United States RNA Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. United States RNA Drugs Market Share in Global Market 2016-2027
Figure 36. United States 5 and 10 Largest RNA Drugs Players Market Share by Revenue in RNA Drugs in 2020
Figure 37. United States RNA Drugs Revenue Share by Type (2016-2021)
Figure 38. United States RNA Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 39. United States RNA Drugs Revenue Share by Application (2016-2021)
Figure 40. United States RNA Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America RNA Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 42. North America RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America RNA Drugs Sales Market Share by Country in 2020
Figure 44. North America RNA Drugs Revenue Market Share by Country in 2020
Figure 45. U.S. RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 46. U.S. RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 48. Canada RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe RNA Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 50. Europe RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe RNA Drugs Sales Market Share by Country in 2020
Figure 52. Europe RNA Drugs Revenue Market Share by Country in 2020
Figure 53. Germany RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. Germany RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. France RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. U.K. RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. Italy RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 62. Russia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific RNA Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 64. Asia Pacific RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific RNA Drugs Sales Market Share by Region in 2020
Figure 66. Asia Pacific RNA Drugs Revenue Market Share by Region in 2020
Figure 67. China RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. China RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. Japan RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. South Korea RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. India RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. Australia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. Taiwan RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Indonesia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Thailand RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 84. Malaysia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 86. Philippines RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 88. Vietnam RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America RNA Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 90. Latin America RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America RNA Drugs Sales Market Share by Country in 2020
Figure 92. Latin America RNA Drugs Revenue Market Share by Country in 2020
Figure 93. Mexico RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 94. Mexico RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 96. Brazil RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 98. Argentina RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa RNA Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 100. Middle East and Africa RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa RNA Drugs Sales Market Share by Country in 2020
Figure 102. Middle East and Africa RNA Drugs Revenue Market Share by Country in 2020
Figure 103. Turkey RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 104. Turkey RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 106. Saudi Arabia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E RNA Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 108. U.A.E RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. RNA Drugs Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
Keyplayers in Global and United States RNA Drugs Market Insights, Forecast to 2027
PfizerRoche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals